Importance of delayed perfusion with primary angioplasty on short-term mortality in acute myocardial infarction patients

Journal of the Medical Association of Thailand

Volumn 90, Issue 12, 2007, Pages 2587-2596

  Kruthkul, Khanat ^a   Srimahachota, Suphot ^a   Udayachalerm, Wasan ^a   Budhari, Wacin ^a   Charipromprasit, Jarkarun ^a   Suitthichayakul, Taworn ^a   Sitthi Amorn, Chitr ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Acute ST elevation myocardial infarction (STEMI); Delay reperfusion; Percutaneous coronary intervention (PCI)

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE;

ACUTE HEART INFARCTION; ANGIOPLASTY; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERFUSION; PREVALENCE; RESUSCITATION; SMOKING HABIT; ST SEGMENT ELEVATION; THORAX PAIN;

ACUTE DISEASE; ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERFUSION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 38649113276     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI) Lancet 1986; 1: 397-402.
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Lancet 1988; 2: 349-60.
3. Cannon CP. Time to treatment of acute myocardial infarction revisited. Curr Opin Cardiol 1998; 13: 254-66.
4. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-94.
5. Edwards WD. Pathology of myocardial infarction and reperfusion. In: Gersh BJ, Rahimtoola SH, editors. Current topics in cardiology: acute myocardial infarction. New York: Elsevier Science; 1991: 14-48.
6. Braunwald E. The open-artery theory is alive and well-again. N Engl J Med 1993; 329: 1650-2.
7. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Buonamici P, et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002; 89: 1248-52.
8. Brodie BR, Stuckey TD, Wall TC, Kissling G, Hansen CJ, Muncy DB, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312-9.
9. Brodie BR, Stone GW, Morice MC, Cox DA, Garcia E, Mattos LA, et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 2001; 88: 1085-90.
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Can J Cardiol 2004; 20: 977-1025.
11. Worachotekamjorn K, Suithichaiyakul T, Srimahachota S, Bhuddari W, Udayachalerm W, Chaipromprasit J, et al. Effect of fast track system on door to balloon time and door to needle time for acute myocardial infarction patients at King Chulalongkorn Memorial hospital. Thai Heart J 2002; 15: 1-10.
12. Zahn R, Vogt A, Zeymer U, Gitt AK, Seidl K, Gottwik M, et al. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart 2005; 91: 1041-6.
13. Brodie BR, Stuckey TD, Hansen CJ, VerSteeg D, Muncy D, Pulsipher M, et al. Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention. Am J Cardiol 2002; 89: 1243-7.
14. Wagner S, Burczyk U, Schiele R, Bergmeier C, Rustige J, Gottwik M, et al. The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J 1998; 19: 879-84.
15. Horie H, Takahashi M, Minai K, Izumi M, Takaoka A, Nozawa M, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998; 98: 2377-82.
16. Cannon CP, Costas TL, Ticfenbunn AJ, French WJ, Gore JM, Weaver D, et al. For the NRMI-2 Investigators: Influence of door to balloon time on mortality in primary angioplasty results in 3648 patients in the second National Registry of Myocardial Infarction (NRMI-2) [abstract]. J Am Coll Cardiol 1996; 27(Suppl A): 61A.
17. Al Mubarak N, Rogers WJ, Lambrew CT, Bowlby LJ, French WJ. Consultation before thrombolytic therapy in acute myocardial infarction. Second National Registry of Myocardial Infarction (NRMI 2) Investigators. Am J Cardiol 1999; 83: 89-93, A8.
18. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circula tion 1999; 100: 14-20.
19. Topol EJ, Califf RM, Lee KL. On behalf of the GUSTO investigators: move on the GUSTO trial [letter]. N Eng J Med. 1994; 331: 227-8.
20. Srimahachota S, Boonyaratavej S, Udayachalerm W, Buddhari W, Chaipromprasit J, Somabutr C, et al. Comparison of primary percutaneous coronary intervention versus thrombolytic therapy in patients with acute myocardial infarction. Thai Heart J 2002; 15: 111-9.
21. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol 1996; 27: 1646-55.
22. Srinivas vs., Vakili BA, Brown DL. Comparison of in-hospital outcomes following early or delayed angioplasty for acute myocardial infarction. J Invasive Cardiol 2002; 14: 746-50.
23. Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 550-7.
24. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991; 325: 1117-22.
25. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators N Engl J Med 1993; 329: 1615-22.